Early drug discovery is a critical phase for the pharmaceutical industry, where the identification and development of novel therapeutic agents commence. Discovering tomorrow's medicine requires the interplay of many disciplines, from screening to medicinal chemistry, biophysics, in vitro and in vivo pharmacology, DMPK as well as toxicology.
In this Meet & Learn, our NUVISAN experts will share their experiences in early drug discovery research, highlighting challenges, and innovative approaches that drive this vital phase of drug development.
